NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









AMT Medical

AMT Medical

Private
EdeHealthcare & Life Scienceshttps://amt-medical.nl/

Last Round

Series B

Apr 17, 2025

Total Funding Raised

$39.2M

Company Overview

AMT Medical is a medical device company which develops the ELANA Heart Bypass System, a minimally invasive, sutureless solution for coronary artery bypass surgery.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

heart bypass systemsutureless anastomosisbeating heart surgeryminimally invasive surgerycoronary artery bypass graftingCABGoff-pump CABGmedical devicemedtechcardiothoracic surgerykeyhole surgeryanastomotic deviceexcimer laser catheterrobotic-assisted surgeryclinical-stage company

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

AMT Medical Comparables

Compare AMT Medical with similar companies based on industry and business-model similarity.

AMT Medical comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
B. Braun SE
74%
Getinge AB
73%
Medtronic
69%

AMT Medical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BApr 17, 2025
GrantOct 1, 2022
Series ASep 28, 2020

Key People

Founding team and executive leadership

Geert van Gansewinkel

Chief Executive Officer

Executive Team

Glenn Bronkers

CTO

Executive Team

AMT Medical Investors

Notable investors and investment history

AMT Medical investors
InvestorRounds
European Innovation Council FundSeries B, Grant
Invest-NLSeries B
Nextgen VenturesSeries A
East Netherlands Development Agency (Oost NL)Series A, Series B
Utrecht HoldingsSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 24, 2026

    Grew 43% QoQ, from 23 to 33 employees.

  • Jan 26, 2026

    Monthly visitors increased 284% MoM, reaching 2.4K.

AMT Medical Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

AMT Medical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about AMT Medical's valuation, stock price, and market status.

Firmographic Details

HeadquartersEde
Employee Range39
Year Founded2017
Last FundingApr 17, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.